Latest Dihydroergotamine Stories
Despite the Continued Launch of Generics, the Migraine Market Will Grow by over $2 Billion from 2013 to 2023, According to Findings from Decision Resources BURLINGTON, Mass., Nov.
POINT RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Transcept Pharmaceuticals Inc.
CARDIFF, Calif., April 8, 2014 /PRNewswire/ -- NI Research has released the April issue of NeuroPerspective,
POINT RICHMOND, Calif., Jan. 13, 2014 /PRNewswire/ -- Transcept Pharmaceuticals, Inc.